Global Early Access Program for eRapa (with Biodexa)

About Tanner Pharma Group

Tanner Pharma Group is a privately held, revenue-generating services company that acts as a critical enabler in the global pharmaceutical supply chain. It partners with pharmaceutical companies, biotechs, and non-profits to navigate complex regulatory, logistical, and distribution challenges, ensuring patients can access medicines through expanded access programs, clinical trial supply, and international commercialization. With a mission-driven focus on health equity, the company leverages two decades of experience and a global network to manage drug shortages, post-trial supply, and market entry strategies for its partners. Its business model is entirely service-based, providing tailored solutions rather than developing its own therapeutic pipeline.

Therapeutic Areas

Other Familial Adenomatous Polyposis (FAP) Drugs